Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ELMD
STRONG BUYFLAGElectromed, Inc. · Healthcare · United States · $318M · Avg Vol: $5M/d
Electromed has the highest quality reading in this batch at Q91, but value at V26 is far below the floor and insiders sold 0.74% of shares outstanding. Excellent business, fully priced, with management taking money off the table.
COMPANY DESCRIPTION
Electromed, Inc. designs, manufactures, and markets airway clearance technologies, primarily its proprietary SmartVest Airway Clearance System, for patients with chronic lung diseases like bronchiectasis. The company operates as a niche market leader in the High Frequency Chest Wall Oscillation (HFCWO) space. Its competitive moat is built on a direct-to-patient distribution model, strong clinical evidence supporting its products, and high reimbursement success rates with insurance providers.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 41.7M | 48.1M | 54.7M | 64.0M | 15.4% | 71.8M | 73.6M | 83.6M | 14.3% |
| EPS | 0.27 | 0.37 | 0.60 | 0.89 | 48.8% | 1.17 | 1.27 | 1.55 | 32.0% |
| Shares | 8.5M | 8.6M | 8.6M | 8.3M | -1.5% | 8.3M | — | — | — |
| Debt | — | — | — | — | — | — | — | — | — |
| Equity | 34.2M | 37.7M | 44.5M | 43.2M | 8.1% | — | — | — | — |
| Op CF | -0.7M | 1.3M | 9.1M | 11.4M | 194.3% | 10.5M | — | — | — |
| Inv CF | -1.5M | -1.7M | -0.4M | -0.3M | — | — | — | — | — |
| Fin CF | -1.5M | -0.4M | 36.0K | -11.9M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ELMD are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ELMD | Electromed, Inc.(you) | $318M | 91 | STRONG BUY |
| VMD | Viemed Healthcare, Inc. | $451M | 96 | STRONG BUY |
| TCMD | Tactile Systems Technology, Inc. | $620M | 88 | STRONG BUY |
| DCTH | Delcath Systems, Inc. | $422M | 75 | BUY |
| BVS | Bioventus Inc. | $799M | 96 | STRONG BUY |
| CNMD | CONMED Corporation | $1.3B | 87 | STRONG BUY |
| IRMD | IRADIMED CORPORATION | $1.2B | 79 | BUY |
| MASS | 908 Devices Inc. | $293M | 52 | HOLD |
| AHCO | AdaptHealth Corp. | $1.5B | 80 | STRONG BUY |
| ENOV | Enovis Corporation | $1.6B | 82 | STRONG BUY |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%